Nanoscale collagen particles and membranes
View Patent ↗Nano scale collagen particles can be obtained from an embrittling and attrition process that reduces the size of collagen particles to the nano scale. These nano scale collagen particles have many favorable properties such as providing beneficial and enhanced properties for cell seeding and wound healing. The nano scale collagen particles can be included in biocompatible (e.g., biostable or biodegradable) compositions and are useful for wound treatment and management, as well as in cell cultures and tissue engineering implants.
1. A method for manufacturing a thin membrane, the method comprising:
placing a composition of collagen particles into a vessel;
embrittling the particles by a process that includes:
contacting the vessel with a cryogenic fluid; and
placing the vessel under vacuum to reduce pressure inside the vessel so as to sublime water from the collagen particles;
reducing a size of the collagen particles obtained from the freeze drying process to have a nano scale dimension, wherein the reducing the size of the collagen particles includes a ball milling process;
mixing the nano scale collagen particles with a biocompatible material that includes a biodegradable polymer selected from the group consisting of polyhydroxyalkonoates, polyesters, polyalkylene esters, polylactic acids, polyglycolic acids, polyamide esters, polyvinyl esters, polyvinylalcohols, polyanhydrides, combinations thereof, copolymers thereof, or monomers thereof; and
spin-coating the biocompatible material and nano scale collagen particles onto a substrate so as to form a thin membrane having the nano scale collagen particles distributed in the biocompatible material.
2. The method of claim 1 , wherein the collagen particles have a dimension greater than about 1 micron prior to embrittling and the nano scale collagen particles have an average dimension of about 1 nm to 1 micron.
3. The method of claim 1 , wherein the substrate includes a silicone rubber.
4. The method of claim 1 , wherein the biocompatible material is provided in a solution from about 1% to about 40% by weight of the solution before spin-coating.
5. The method of claim 1 , wherein the thin membrane has a thickness from about 1 micron to about 100 microns.
6. The method of claim 1 , further comprising mixing an active pharmaceutical ingredient with the biocompatible material and collagen particles.
7. The method of claim 1 , further comprising configuring the thin membrane into one of the following:
a wound dressing;
a tissue scaffold; or
a cell culture insert having a shape configured to be received into a cell culture chamber.
8. The method of claim 1 , wherein reducing the size of the collagen particles includes high energy attrition.
9. The method of claim 1 , wherein the nano scale collagen particles are substantially uniformly distributed within the biodegradable material.
10. A method for manufacturing a thin membrane, the method comprising:
placing a composition of collagen particles into a vessel;
embrittling a composition of collagen particles by a process that includes:
contacting the vessel with a cryogenic fluid; and
placing the vessel under vacuum to reduce pressure inside the vessel so as to sublime water from the collagen particles;
reducing a size of the collagen particles obtained from the embrittling process by a process that includes ball milling at a selected RPM and for a selected time such that the resultant collagen particles have a nano scale dimension;
mixing the nano scale collagen particles with a biocompatible material that includes a biodegradable polymer selected from the group consisting of polyhydroxyalkonoates, polyesters, polyalkylene esters, polylactic acids, polyglycolic acids, polyamide esters, polyvinyl esters, polyvinylalcohols, polyanhydrides, combinations thereof, copolymers thereof, or monomers thereof;
spin-coating the biocompatible material and nano scale collagen particles onto a substrate so as to form a thin membrane having the nano scale collagen particles distributed in the biocompatible material; and
preparing the thin membrane into a wound dressing.
11. The method of claim 10 , wherein the collagen particles have a dimension greater than about 1 micron prior to embrittling and the nano scale collagen particles have an average dimension of about 1 nm to 1 micron.
12. The method of claim 10 , wherein the substrate includes a silicone rubber.
13. The method of claim 10 , wherein the biocompatible material is provided in a solution from about 1% to about 40% by weight of the solution before spin-coating.
14. The method of claim 10 , wherein the thin membrane has a thickness from about 1 micron to about 100 microns.
15. The method of claim 10 , further comprising mixing an active pharmaceutical ingredient with the biocompatible material and collagen particles.
16. The method of claim 10 , wherein reducing the size of the collagen particles includes high energy attrition.
17. The method of claim 10 , wherein the nano scale collagen particles are substantially uniformly distributed within the biodegradable material.